Billions of non-dilutive dollars are awarded annually across scientific fields, mainly from NIH, DOD, and other government sources. In 2016 alone, domestic for-profit organizations received approximately $2.7 billion from awards ranging from $200k to multi-millions; ~$2 billion came from non-SBIR funders. In this presentation, Meytal Waiss of the FreeMind Group will give an overview of the non-dilutive funding landscape with an emphasis on NIH, DOD, and BARDA. She will discuss alternatives to SBIR/STTR, and describe the various mechanisms and pockets of money available, potential for funding, and means to maximize your chances of winning an award. Download the slide deck
Where and When
Room 212, Byers Hall, UCSF Mission Bay (1700 4th St., San Francisco)
12:00-1:00 pm, Thursday, June 15
About the Speaker
Meytal Waiss, Director of Business Development at FreeMind, has spent most of her career as a part of the scientific community. Previously a Senior Project Manager in FreeMind’s Professional Department, Meytal has helped clients manage the complex application production process, submit, and win, and is now utilizing her strong background in the life sciences, grant writing, and understanding of non-dilutive funding to guide potential clients through the first stages of the process. Meytal holds a Master’s degree in Cellular and Developmental Biology from the Hebrew University of Jerusalem, where she specialized in Neurodegenerative Diseases and Microscopy.